Delivery Order SPE2DB24D2109-SPE2DB24FHVVX

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of Omnipod Dash Pods (Gen 4) medical devices. The contract has a ceiling value of $5,592.48 and is a firm fixed-price delivery order with a completion date of May 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award, with a ceiling value of $6,908.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Omnipod DASH Pods (Gen 4) 5-packs, which are medical devices used in the management of diabetes. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $34,491.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The delivery order contract is for the supply of 4565392048 Omnipod Dash Pods (Gen 4) 5-packs, which are medical supplies used to support various government healthcare programs and military treatment facilities. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,923.94, is for the delivery of Omnipod Dash Pods (Gen 4) medical devices. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999, which provides a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $14,700.37 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is to supply OMNIPOD DASH PODS (GEN 4) 5PK 5S medical devices, with a completion date of December 3, 2024. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract, valued at $5,557.01, is for the delivery of Omnipod Dash Pods (Gen 4) medical devices. It is a firm-fixed-price delivery order contract with an ultimate completion date of August 13, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential medical supplies to support military treatment...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order (SPE2DB23FP63B) under an Indefinite Delivery Contract (SPE2DB20D1109) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $18,682.13, is for the supply of Omnipod Dash Pods (Gen 4) medical devices. The contract has no set-aside designation, indicating open competition. Amerisourcebergen maintains a $999,999,999 IDC with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,645.02, is a firm fixed-price delivery order for Omnipod Dash Pods (Gen 4) 5PK 5S medical devices. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,951.29 Firm Fixed Price delivery order is for the supply of Omnipod Dash Pods (Gen 4) 5-packs to support military healthcare programs. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,371.45, is for the procurement of OMNIPOD DASH PODS (GEN 4) 5PK 5S medical devices. The contract has an ultimate completion date of June 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB24D2109
    Indefinite Delivery Contract
  • SPE2DB24D2109-SPE2DB24FHVVX
    Delivery Order

This federal contract award, valued at $24,154.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Omnipod Dash Pods (Gen 4) 5PK 5S, a medical device, and does not have a set-aside designation.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 5/17/25, 10:10 AM